Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 351 entries
Sorted by: Best Match Show Resources per page
The consumer's risk in clinical trials.

Molecular biotherapy

Kramer BS.
PMID: 2222896
Mol Biother. 1990 Sep;2(3):132-6.

In any formal statistical test of the null hypothesis (the statement that a population parameter is equal to a specific value), there are two possible types of error. Type 1 or alpha error has occurred if the investigator rejects...

Cite
Kramer BS. The consumer's risk in clinical trials. Mol Biother. 1990;2(3):132-6
Kramer, B. S. (1990). The consumer's risk in clinical trials. Molecular biotherapy, 2(3), 132-6.
Kramer, B S. "The consumer's risk in clinical trials." Molecular biotherapy vol. 2,3 (1990): 132-6.
Kramer BS. The consumer's risk in clinical trials. Mol Biother. 1990 Sep;2(3):132-6. PMID: 2222896.
Copy Download .nbib Format: NLM
Hybrid Self-Assembly during Evaporation Enables Drop-on-Demand Thin Film Devices.

ACS applied materials & interfaces

Boley JW, Hyun SH, White EL, Thompson DH, Kramer RK.
PMID: 27008567
ACS Appl Mater Interfaces. 2016 Dec 21;8(50):34171-34178. doi: 10.1021/acsami.5b12687. Epub 2016 Apr 01.

We propose and demonstrate a hybrid self-assembly process as the mechanism for producing strikingly uniform deposits from evaporating drops composed of cosolvents. This assembly process leverages both particle-fluid interactions to carry the particles to the drop surface and particle-interface...

Cite
Boley JW, Hyun SH, White EL, et al. Hybrid Self-Assembly during Evaporation Enables Drop-on-Demand Thin Film Devices. ACS Appl Mater Interfaces. 2016;8(50):34171-34178doi: 10.1021/acsami.5b12687.
Boley, J. W., Hyun, S. H., White, E. L., Thompson, D. H., & Kramer, R. K. (2016). Hybrid Self-Assembly during Evaporation Enables Drop-on-Demand Thin Film Devices. ACS applied materials & interfaces, 8(50), 34171-34178. https://doi.org/10.1021/acsami.5b12687
Boley, J William, et al. "Hybrid Self-Assembly during Evaporation Enables Drop-on-Demand Thin Film Devices." ACS applied materials & interfaces vol. 8,50 (2016): 34171-34178. doi: https://doi.org/10.1021/acsami.5b12687
Boley JW, Hyun SH, White EL, Thompson DH, Kramer RK. Hybrid Self-Assembly during Evaporation Enables Drop-on-Demand Thin Film Devices. ACS Appl Mater Interfaces. 2016 Dec 21;8(50):34171-34178. doi: 10.1021/acsami.5b12687. Epub 2016 Apr 01. PMID: 27008567.
Copy Download .nbib Format: NLM
[Debate on target blood pressure after SPRINT].

MMW Fortschritte der Medizin

Hausberg M, Krämer B, Gray KL.
PMID: 28924762
MMW Fortschr Med. 2016 Jan;158(1):60-62. doi: 10.1007/s15006-016-7704-4.

No abstract available.

Cite
Hausberg M, Krämer B, Gray KL. „Die Versorgungsrealität im Blick behalten“. [Debate on target blood pressure after SPRINT]. MMW Fortschr Med. 2016;158(1):60-62doi: 10.1007/s15006-016-7704-4.
Hausberg, M., Krämer, B., & Gray, K. L. (2016). „Die Versorgungsrealität im Blick behalten“. [Debate on target blood pressure after SPRINT]. MMW Fortschritte der Medizin, 158(1), 60-62. https://doi.org/10.1007/s15006-016-7704-4
Hausberg, Martin, et al. "„Die Versorgungsrealität im Blick behalten“." [Debate on target blood pressure after SPRINT]. MMW Fortschritte der Medizin vol. 158,1 (2016): 60-62. doi: https://doi.org/10.1007/s15006-016-7704-4
Hausberg M, Krämer B, Gray KL. „Die Versorgungsrealität im Blick behalten“. [Debate on target blood pressure after SPRINT]. MMW Fortschr Med. 2016 Jan;158(1):60-62. doi: 10.1007/s15006-016-7704-4. German. PMID: 28924762.
Copy Download .nbib Format: NLM
Demonstration of a beam loaded nanocoulomb-class laser wakefield accelerator.

Nature communications

Couperus JP, Pausch R, Köhler A, Zarini O, Krämer JM, Garten M, Huebl A, Gebhardt R, Helbig U, Bock S, Zeil K, Debus A, Bussmann M, Schramm U, Irman A.
PMID: 28887456
Nat Commun. 2017 Sep 08;8(1):487. doi: 10.1038/s41467-017-00592-7.

Laser-plasma wakefield accelerators have seen tremendous progress, now capable of producing quasi-monoenergetic electron beams in the GeV energy range with few-femtoseconds bunch duration. Scaling these accelerators to the nanocoulomb range would yield hundreds of kiloamperes peak current and stimulate...

Cite
Couperus JP, Pausch R, Köhler A, et al. Demonstration of a beam loaded nanocoulomb-class laser wakefield accelerator. Nat Commun. 2017;8(1):487doi: 10.1038/s41467-017-00592-7.
Couperus, J. P., Pausch, R., Köhler, A., Zarini, O., Krämer, J. M., Garten, M., Huebl, A., Gebhardt, R., Helbig, U., Bock, S., Zeil, K., Debus, A., Bussmann, M., Schramm, U., & Irman, A. (2017). Demonstration of a beam loaded nanocoulomb-class laser wakefield accelerator. Nature communications, 8(1), 487. https://doi.org/10.1038/s41467-017-00592-7
Couperus, J P, et al. "Demonstration of a beam loaded nanocoulomb-class laser wakefield accelerator." Nature communications vol. 8,1 (2017): 487. doi: https://doi.org/10.1038/s41467-017-00592-7
Couperus JP, Pausch R, Köhler A, Zarini O, Krämer JM, Garten M, Huebl A, Gebhardt R, Helbig U, Bock S, Zeil K, Debus A, Bussmann M, Schramm U, Irman A. Demonstration of a beam loaded nanocoulomb-class laser wakefield accelerator. Nat Commun. 2017 Sep 08;8(1):487. doi: 10.1038/s41467-017-00592-7. PMID: 28887456; PMCID: PMC5591198.
Copy Download .nbib Format: NLM
Quasi-2D Heisenberg Antiferromagnets [CuX(pyz).

Inorganic chemistry

Kubus M, Lanza A, Scatena R, Dos Santos LHR, Wehinger B, Casati N, Fiolka C, Keller L, Macchi P, Rüegg C, Krämer KW.
PMID: 29389126
Inorg Chem. 2018 May 07;57(9):4934-4943. doi: 10.1021/acs.inorgchem.7b03150. Epub 2018 Feb 01.

Two Cu

Cite
Kubus M, Lanza A, Scatena R, et al. Quasi-2D Heisenberg Antiferromagnets [CuX(pyz). Inorg Chem. 2018;57(9):4934-4943doi: 10.1021/acs.inorgchem.7b03150.
Kubus, M., Lanza, A., Scatena, R., Dos Santos, L. H. R., Wehinger, B., Casati, N., Fiolka, C., Keller, L., Macchi, P., Rüegg, C., & Krämer, K. W. (2018). Quasi-2D Heisenberg Antiferromagnets [CuX(pyz). Inorganic chemistry, 57(9), 4934-4943. https://doi.org/10.1021/acs.inorgchem.7b03150
Kubus, Mariusz, et al. "Quasi-2D Heisenberg Antiferromagnets [CuX(pyz)." Inorganic chemistry vol. 57,9 (2018): 4934-4943. doi: https://doi.org/10.1021/acs.inorgchem.7b03150
Kubus M, Lanza A, Scatena R, Dos Santos LHR, Wehinger B, Casati N, Fiolka C, Keller L, Macchi P, Rüegg C, Krämer KW. Quasi-2D Heisenberg Antiferromagnets [CuX(pyz). Inorg Chem. 2018 May 07;57(9):4934-4943. doi: 10.1021/acs.inorgchem.7b03150. Epub 2018 Feb 01. PMID: 29389126.
Copy Download .nbib Format: NLM
Mass spectrometric analysis of long chain alk-1-enyl ether esters and alkyl ether esters of diols.

Lipids

Kramer JK, Baumann WJ, Holman RT.
PMID: 27519359
Lipids. 1971 Jul;6(7):492-501. doi: 10.1007/BF02531235.

The mass spectra of homologous series of long chain alk-1-enyl ether esters and alkyl ether esters of short chain diols were determined, and general patterns of fragmentation were established. Both types of diol lipids yielded ions characteristic of the...

Cite
Kramer JK, Baumann WJ, Holman RT. Mass spectrometric analysis of long chain alk-1-enyl ether esters and alkyl ether esters of diols. Lipids. 1971;6(7):492-501doi: 10.1007/BF02531235.
Kramer, J. K., Baumann, W. J., & Holman, R. T. (1971). Mass spectrometric analysis of long chain alk-1-enyl ether esters and alkyl ether esters of diols. Lipids, 6(7), 492-501. https://doi.org/10.1007/BF02531235
Kramer, J K, et al. "Mass spectrometric analysis of long chain alk-1-enyl ether esters and alkyl ether esters of diols." Lipids vol. 6,7 (1971): 492-501. doi: https://doi.org/10.1007/BF02531235
Kramer JK, Baumann WJ, Holman RT. Mass spectrometric analysis of long chain alk-1-enyl ether esters and alkyl ether esters of diols. Lipids. 1971 Jul;6(7):492-501. doi: 10.1007/BF02531235. PMID: 27519359.
Copy Download .nbib Format: NLM
Radiofrequency Volumetric Thermal Ablation of Fibroids and Laparoscopic Myomectomy: Long-Term Follow-up From a Randomized Trial.

Geburtshilfe und Frauenheilkunde

Hahn M, Brucker S, Kraemer D, Wallwiener M, Taran FA, Wallwiener CW, Krämer B.
PMID: 26097247
Geburtshilfe Frauenheilkd. 2015 May;75(5):442-449. doi: 10.1055/s-0035-1545931.

No abstract available.

Cite
Hahn M, Brucker S, Kraemer D, et al. Radiofrequency Volumetric Thermal Ablation of Fibroids and Laparoscopic Myomectomy: Long-Term Follow-up From a Randomized Trial. Geburtshilfe Frauenheilkd. 2015;75(5):442-449doi: 10.1055/s-0035-1545931.
Hahn, M., Brucker, S., Kraemer, D., Wallwiener, M., Taran, F. A., Wallwiener, C. W., & Krämer, B. (2015). Radiofrequency Volumetric Thermal Ablation of Fibroids and Laparoscopic Myomectomy: Long-Term Follow-up From a Randomized Trial. Geburtshilfe und Frauenheilkunde, 75(5), 442-449. https://doi.org/10.1055/s-0035-1545931
Hahn, M, et al. "Radiofrequency Volumetric Thermal Ablation of Fibroids and Laparoscopic Myomectomy: Long-Term Follow-up From a Randomized Trial." Geburtshilfe und Frauenheilkunde vol. 75,5 (2015): 442-449. doi: https://doi.org/10.1055/s-0035-1545931
Hahn M, Brucker S, Kraemer D, Wallwiener M, Taran FA, Wallwiener CW, Krämer B. Radiofrequency Volumetric Thermal Ablation of Fibroids and Laparoscopic Myomectomy: Long-Term Follow-up From a Randomized Trial. Geburtshilfe Frauenheilkd. 2015 May;75(5):442-449. doi: 10.1055/s-0035-1545931. PMID: 26097247; PMCID: PMC4461677.
Copy Download .nbib Format: NLM
Coherence analysis discriminates between retroviral integration patterns in CD34(+) cells transduced under differing clinical trial conditions.

Molecular therapy. Methods & clinical development

Hallwirth CV, Garg G, Peters TJ, Kramer BA, Malani NV, Hyman J, Ruan X, Ginn SL, Hetherington NA, Veeravalli L, Shahab A, Ranganathan S, Wei CL, Liddle C, Thrasher AJ, Bushman FD, Buckley MJ, Alexander IE.
PMID: 26029726
Mol Ther Methods Clin Dev. 2015 Apr 29;2:15015. doi: 10.1038/mtm.2015.15. eCollection 2015.

Unequivocal demonstration of the therapeutic utility of γ-retroviral vectors for gene therapy applications targeting the hematopoietic system was accompanied by instances of insertional mutagenesis. These events stimulated the ongoing development of putatively safer integrating vector systems and analysis methods...

Cite
Hallwirth CV, Garg G, Peters TJ, et al. Coherence analysis discriminates between retroviral integration patterns in CD34(+) cells transduced under differing clinical trial conditions. Mol Ther Methods Clin Dev. 2015;2:15015doi: 10.1038/mtm.2015.15.
Hallwirth, C. V., Garg, G., Peters, T. J., Kramer, B. A., Malani, N. V., Hyman, J., Ruan, X., Ginn, S. L., Hetherington, N. A., Veeravalli, L., Shahab, A., Ranganathan, S., Wei, C. L., Liddle, C., Thrasher, A. J., Bushman, F. D., Buckley, M. J., & Alexander, I. E. (2015). Coherence analysis discriminates between retroviral integration patterns in CD34(+) cells transduced under differing clinical trial conditions. Molecular therapy. Methods & clinical development, 215015. https://doi.org/10.1038/mtm.2015.15
Hallwirth, Claus V, et al. "Coherence analysis discriminates between retroviral integration patterns in CD34(+) cells transduced under differing clinical trial conditions." Molecular therapy. Methods & clinical development vol. 2 (2015): 15015. doi: https://doi.org/10.1038/mtm.2015.15
Hallwirth CV, Garg G, Peters TJ, Kramer BA, Malani NV, Hyman J, Ruan X, Ginn SL, Hetherington NA, Veeravalli L, Shahab A, Ranganathan S, Wei CL, Liddle C, Thrasher AJ, Bushman FD, Buckley MJ, Alexander IE. Coherence analysis discriminates between retroviral integration patterns in CD34(+) cells transduced under differing clinical trial conditions. Mol Ther Methods Clin Dev. 2015 Apr 29;2:15015. doi: 10.1038/mtm.2015.15. eCollection 2015. PMID: 26029726; PMCID: PMC4445430.
Copy Download .nbib Format: NLM
Corrigendum: Structure and Composition of the 200 K-Superconducting Phase of H.

Angewandte Chemie (International ed. in English)

Gordon EE, Xu K, Xiang H, Bussmann-Holder A, Kremer RK, Simon A, Köhler J, Whangbo MH.
PMID: 27709820
Angew Chem Int Ed Engl. 2016 Oct 10;55(42):12941-12942. doi: 10.1002/anie.201603460.

No abstract available.

Cite
Gordon EE, Xu K, Xiang H, et al. Corrigendum: Structure and Composition of the 200 K-Superconducting Phase of H. Angew Chem Int Ed Engl. 2016;55(42):12941-12942doi: 10.1002/anie.201603460.
Gordon, E. E., Xu, K., Xiang, H., Bussmann-Holder, A., Kremer, R. K., Simon, A., Köhler, J., & Whangbo, M. H. (2016). Corrigendum: Structure and Composition of the 200 K-Superconducting Phase of H. Angewandte Chemie (International ed. in English), 55(42), 12941-12942. https://doi.org/10.1002/anie.201603460
Gordon, Elijah E, et al. "Corrigendum: Structure and Composition of the 200 K-Superconducting Phase of H." Angewandte Chemie (International ed. in English) vol. 55,42 (2016): 12941-12942. doi: https://doi.org/10.1002/anie.201603460
Gordon EE, Xu K, Xiang H, Bussmann-Holder A, Kremer RK, Simon A, Köhler J, Whangbo MH. Corrigendum: Structure and Composition of the 200 K-Superconducting Phase of H. Angew Chem Int Ed Engl. 2016 Oct 10;55(42):12941-12942. doi: 10.1002/anie.201603460. PMID: 27709820.
Copy Download .nbib Format: NLM
Correction: Contactin-1 and Neurofascin-155/-186 Are Not Targets of Auto-Antibodies in Multifocal Motor Neuropathy.

PloS one

Doppler K, Appeltshauser L, Krämer HH, Ng JK, Meinl E, Villmann C, Brophy P, Dib-Hajj SD, Waxman SG, Weishaupt A, Sommer C.
PMID: 26317434
PLoS One. 2015 Aug 28;10(8):e0137443. doi: 10.1371/journal.pone.0137443. eCollection 2015.

No abstract available.

Cite
Doppler K, Appeltshauser L, Krämer HH, et al. Correction: Contactin-1 and Neurofascin-155/-186 Are Not Targets of Auto-Antibodies in Multifocal Motor Neuropathy. PLoS One. 2015;10(8):e0137443doi: 10.1371/journal.pone.0137443.
Doppler, K., Appeltshauser, L., Krämer, H. H., Ng, J. K., Meinl, E., Villmann, C., Brophy, P., Dib-Hajj, S. D., Waxman, S. G., Weishaupt, A., & Sommer, C. (2015). Correction: Contactin-1 and Neurofascin-155/-186 Are Not Targets of Auto-Antibodies in Multifocal Motor Neuropathy. PloS one, 10(8), e0137443. https://doi.org/10.1371/journal.pone.0137443
Doppler, Kathrin, et al. "Correction: Contactin-1 and Neurofascin-155/-186 Are Not Targets of Auto-Antibodies in Multifocal Motor Neuropathy." PloS one vol. 10,8 (2015): e0137443. doi: https://doi.org/10.1371/journal.pone.0137443
Doppler K, Appeltshauser L, Krämer HH, Ng JK, Meinl E, Villmann C, Brophy P, Dib-Hajj SD, Waxman SG, Weishaupt A, Sommer C. Correction: Contactin-1 and Neurofascin-155/-186 Are Not Targets of Auto-Antibodies in Multifocal Motor Neuropathy. PLoS One. 2015 Aug 28;10(8):e0137443. doi: 10.1371/journal.pone.0137443. eCollection 2015. PMID: 26317434; PMCID: PMC4552886.
Copy Download .nbib Format: NLM
Physical Activity Levels in a Community Lifestyle Intervention: A Randomized Trial.

Translational journal of the American College of Sports Medicine

Eaglehouse YL, Rockette-Wagner B, Kramer MK, Arena VC, Miller RG, Vanderwood KK, Kriska AM.
PMID: 27551690
Transl J Am Coll Sports Med. 2016 Jun 01;1(5):45-51.

BACKGROUND: A behavioral lifestyle intervention program with goals of increasing physical activity (PA) and losing weight was shown to be efficacious for preventing type 2 diabetes and decreasing risk for cardiovascular disease in the U.S. Diabetes Prevention Program (DPP)....

Cite
Eaglehouse YL, Rockette-Wagner B, Kramer MK, et al. Physical Activity Levels in a Community Lifestyle Intervention: A Randomized Trial. Transl J Am Coll Sports Med. 2016;1(5):45-51
Eaglehouse, Y. L., Rockette-Wagner, B., Kramer, M. K., Arena, V. C., Miller, R. G., Vanderwood, K. K., & Kriska, A. M. (2016). Physical Activity Levels in a Community Lifestyle Intervention: A Randomized Trial. Translational journal of the American College of Sports Medicine, 1(5), 45-51.
Eaglehouse, Yvonne L, et al. "Physical Activity Levels in a Community Lifestyle Intervention: A Randomized Trial." Translational journal of the American College of Sports Medicine vol. 1,5 (2016): 45-51.
Eaglehouse YL, Rockette-Wagner B, Kramer MK, Arena VC, Miller RG, Vanderwood KK, Kriska AM. Physical Activity Levels in a Community Lifestyle Intervention: A Randomized Trial. Transl J Am Coll Sports Med. 2016 Jun 01;1(5):45-51. PMID: 27551690; PMCID: PMC4991779.
Copy Download .nbib Format: NLM
Response to Dr Fried & Dr Kievit, and Dr Malhi et al.

Molecular psychiatry

Schmaal L, Veltman DJ, van Erp TG, Sämann PG, Frodl T, Jahanshad N, Loehrer E, Vernooij MW, Niessen WJ, Ikram MA, Wittfeld K, Grabe HJ, Block A, Hegenscheid K, Hoehn D, Czisch M, Lagopoulos J, Hatton SN, Hickie IB, Goya-Maldonado R, Krämer B, Gruber O, Couvy-Duchesne B, Rentería ME, Strike LT, Wright MJ, de Zubicaray GI, McMahon KL, Medland SE, Gillespie NA, Hall GB, van Velzen LS, van Tol MJ, van der Wee NJ, Veer IM, Walter H, Schramm E, Normann C, Schoepf D, Konrad C, Zurowski B, McIntosh AM, Whalley HC, Sussmann JE, Godlewska BR, Fischer FH, Penninx BW, Thompson PM, Hibar DP.
PMID: 26903270
Mol Psychiatry. 2016 Jun;21(6):726-8. doi: 10.1038/mp.2016.9. Epub 2016 Feb 23.

No abstract available.

Cite
Schmaal L, Veltman DJ, van Erp TG, et al. Response to Dr Fried & Dr Kievit, and Dr Malhi et al. Mol Psychiatry. 2016;21(6):726-8doi: 10.1038/mp.2016.9.
Schmaal, L., Veltman, D. J., van Erp, T. G., Sämann, P. G., Frodl, T., Jahanshad, N., Loehrer, E., Vernooij, M. W., Niessen, W. J., Ikram, M. A., Wittfeld, K., Grabe, H. J., Block, A., Hegenscheid, K., Hoehn, D., Czisch, M., Lagopoulos, J., Hatton, S. N., Hickie, I. B., Goya-Maldonado, R., Krämer, B., Gruber, O., Couvy-Duchesne, B., Rentería, M. E., Strike, L. T., Wright, M. J., de Zubicaray, G. I., McMahon, K. L., Medland, S. E., Gillespie, N. A., Hall, G. B., van Velzen, L. S., van Tol, M. J., van der Wee, N. J., Veer, I. M., Walter, H., Schramm, E., Normann, C., Schoepf, D., Konrad, C., Zurowski, B., McIntosh, A. M., Whalley, H. C., Sussmann, J. E., Godlewska, B. R., Fischer, F. H., Penninx, B. W., Thompson, P. M., & Hibar, D. P. (2016). Response to Dr Fried & Dr Kievit, and Dr Malhi et al. Molecular psychiatry, 21(6), 726-8. https://doi.org/10.1038/mp.2016.9
Schmaal, L, et al. "Response to Dr Fried & Dr Kievit, and Dr Malhi et al." Molecular psychiatry vol. 21,6 (2016): 726-8. doi: https://doi.org/10.1038/mp.2016.9
Schmaal L, Veltman DJ, van Erp TG, Sämann PG, Frodl T, Jahanshad N, Loehrer E, Vernooij MW, Niessen WJ, Ikram MA, Wittfeld K, Grabe HJ, Block A, Hegenscheid K, Hoehn D, Czisch M, Lagopoulos J, Hatton SN, Hickie IB, Goya-Maldonado R, Krämer B, Gruber O, Couvy-Duchesne B, Rentería ME, Strike LT, Wright MJ, de Zubicaray GI, McMahon KL, Medland SE, Gillespie NA, Hall GB, van Velzen LS, van Tol MJ, van der Wee NJ, Veer IM, Walter H, Schramm E, Normann C, Schoepf D, Konrad C, Zurowski B, McIntosh AM, Whalley HC, Sussmann JE, Godlewska BR, Fischer FH, Penninx BW, Thompson PM, Hibar DP. Response to Dr Fried & Dr Kievit, and Dr Malhi et al. Mol Psychiatry. 2016 Jun;21(6):726-8. doi: 10.1038/mp.2016.9. Epub 2016 Feb 23. PMID: 26903270; PMCID: PMC4876636.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 351 entries